To: Tenchusatsu who wrote (230305 ) 4/22/2005 12:33:09 PM From: Alighieri Read Replies (3) | Respond to of 1573922 Seems like that's where the whole process of life begins. What do you think of the implications of this little tid bit? Al ================================================ Ailing Specter Now Pushes Stem Cell Research Sen. Specter Pushes Stem Cell Research With New Perspective, Now Ill With Hodgkin's Disease By KEVIN FREKING Associated Press Writer The Associated PressThe Associated Press WASHINGTON Apr 21, 2005 — Sen. Arlen Specter is pushing legislation to expand stem cell research with the perspective of a man fighting a deadly illness. The Pennsylvania Republican has Hodgkin's disease, a cancer of the lymph system, and is being treated with chemotherapy. He and two colleagues introduced a bill Thursday that would allow for what is often referred to as therapeutic cloning. "I've got a new hairdo, which you can all observe, and that is indicative of a problem which may well be helped by stem cell research if it were to go forward," said Specter, referring to the loss of most of his hair. Top Stories Specter was joined at a news conference by Sens. Orrin Hatch of Utah, a conservative Republican, and Diane Feinstein of California, a liberal Democrat. The three said their bill would make reproductive cloning, to produce a baby, a crime punishable by up to 10 years. But they do want to allow for "therapeutic cloning" for the purpose of obtaining stem cells to be used in treating disease. Therapeutic cloning requires the destruction of an embryo, and therefore opponents argue that destroying it is the same as destroying life. Specter, a co-sponsor of stem cell legislation in the last Congress, said he believes the United States needs to place more emphasis on health care research. "I do not think that we are spending the right priorities with respect to our health care budget," he said. "I don't choose to unduly personalize it, but I have to find some way to excuse my hairdo." Copyright 2005 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.